Synthesis, α‑Glucosidase, α‑Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2‑ a ]pyridine Derivatives
ACS Omega · 22.10.2024 · 9 (42) · 42905-42914
DOI: 10.1021/acsomega.4c05619 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 11.10.2024. Verfasst von Betül Kaya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, 67600 Zonguldak, Turkey. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inhibition ofaldose reductase (AR), α-glycosidase (α-GLY), and α-amylase (α-AMY) are some of the essential targets in diabetes mellitus (DM). Here, a series of imidazo[1,2-a]pyridine-based 1,3,4-thiadiazole derivatives (8a–k) were successfully synthesized and characterized using 1H NMR, 13C NMR, and HRMS spectroscopic techniques. The inhibition effects of the synthesized derivatives against AR, α-GLY, and α-AMY were evaluated using both in vitro and in silico methods. In vitro studies revealed that the derivatives (8a–k) showed significant inhibition activity. The results showed that the novel derivatives (8a–k) demonstrated potential inhibitory activity, with KI values covering the following ranges: 23.47 ± 2.40 to 139.60 ± 13.33 nM for AR and 6.09 ± 0.37 to 119.80 ± 12.31 μM for α-GLY, with IC50 values 81.14 to 153.51 μM for α-AMY. Furthermore, many of these compounds exhibited high inhibition activity, while some of them showed higher potency than the reference compounds. Molecular docking of the target compounds was carried out in the active sites of AR (PDB ID: 4JIR) and α-GLY (PDB ID: 5NN8).
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, 67600 Zonguldak, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey.
- Vocational School of Health Services, Bilecik Şeyh Edebali University, 11230 Bilecik, Turkey.
- Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, 36100 Kars, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, 24002 Erzincan, Turkey.
- Department of Bioengineering, Faculty of Engineering, Bilecik Şeyh Edebali University, 11230 Bilecik, Turkey.
ORCID-Profile: Ulviye Acar Çevik, Cüneyt Türkeş, Hayrani Eren Bostancı, Şükrü Beydemir
Zitieren
APA
Kaya, B., Acar Çevik, U., Çiftçi, B., Duran, H. E., Türkeş, C., Işık, M., Bostancı, H. E., Kaplancıklı, Z. A., & Beydemir, Ş. (2024). Synthesis, α‑Glucosidase, α‑Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2‑ a ]pyridine Derivatives. ACS Omega, 9(42), 42905-42914. https://doi.org/10.1021/acsomega.4c05619
Vancouver
Kaya B, Acar Çevik U, Çiftçi B, Duran HE, Türkeş C, Işık M, et al. Synthesis, α‑Glucosidase, α‑Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2‑ a ]pyridine Derivatives. ACS Omega. 2024;9(42):42905-42914. doi:10.1021/acsomega.4c05619
BibTeX
@article{Kaya2024,
author = {Kaya, Betül and Acar Çevik, Ulviye and Çiftçi, Bilge and Duran, Hatice Esra and Türkeş, Cüneyt and Işık, Mesut and Bostancı, Hayrani Eren and Kaplancıklı, Zafer Asım and Beydemir, Şükrü},
title = {Synthesis, α‑Glucosidase, α‑Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2‑ a ]pyridine Derivatives},
journal = {ACS Omega},
year = {2024},
volume = {9},
number = {42},
pages = {42905--42914},
doi = {10.1021/acsomega.4c05619}
}
EUVIMED